The European Patent Office published patent application EP3167046A1 for Targazyme Inc., covering methods of cryopreservation of fucosylated cells for therapeutic use. The application claims priority in IPC classifications including A61K 35/12, A61K 35/17, A61K 35/28, C12N 5/00, C12N 9/10, and A01N 1/125. The patent designates all EU member states plus Switzerland, Liechtenstein, Norway, Turkey, and other European states.

This is a patent publication notification with no compliance obligations. Entities in the cell therapy, biotechnology, or pharmaceutical manufacturing sectors should review to assess potential patent landscape implications for their research and development activities.